Quantcast

Vasopressin-receptor antagonist therapy in patients with hyponatraemia.

Research paper by Tushar T Vachharajani, Vidula V Vachharajani

Indexed on: 01 Aug '07Published on: 01 Aug '07Published in: British journal of hospital medicine (London, England : 2005)



Abstract

Hyponatraemia often complicates the treatment of underlying conditions in patients who are seriously ill. Arginine vasopressin receptor antagonists block the action of arginine vasopressin and correct sodium and water imbalance in patients with euvolaemic or hypervolaemic hyponatraemia.